| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |